Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer-Reference-Cited by-同舟云学术

Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer

Published:2017-05-09 Issue:11 Volume:19 Page:1481-1493
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Van Swearingen Amanda E D,Sambade Maria J,Siegel Marni B,Sud Shivani,McNeill Robert S,Bevill Samantha M,Chen Xin,Bash Ryan E,Mounsey Louisa,Golitz Brian T,Santos Charlene,Deal Allison,Parker Joel S,Rashid Naim,Miller C Ryan,Johnson Gary L,Anders Carey K

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/19/11/1481/22934197/nox052.pdf

Reference47 articles.

1. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer;Clin Breast Cancer,2009

2. Molecular portraits of human breast tumours;Nature,2000

3. Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse;Breast Cancer Res Treat,2012

4. Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases;Cancer,2008

5. Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT);Ann Oncol,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer.;Cancer Letters;2024-09

2. Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer;Journal of Nanobiotechnology;2024-07-20

3. Design, synthesis, molecular docking, and in vitro studies of 2-mercaptoquinazolin-4(3H)-ones as potential anti-breast cancer agents;Saudi Pharmaceutical Journal;2024-03

4. Small molecule agents for triple negative breast cancer: Current status and future prospects;Translational Oncology;2024-03

5. Synergistic effects of inhibitors targeting PI3K and Aurora Kinase A in preclinical inflammatory breast cancer models;2023-08-13